↓ Skip to main content

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

patent
13 patents

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
50 Mendeley
Title
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
Published in
Cancer Chemotherapy and Pharmacology, May 2012
DOI 10.1007/s00280-012-1875-1
Pubmed ID
Authors

Alberto Zaniboni, Enrico Aitini, Sandro Barni, Daris Ferrari, Stefano Cascinu, Vincenzo Catalano, Giuseppe Valmadre, Domenica Ferrara, Enzo Veltri, Claudio Codignola, Roberto Labianca

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Other 10 20%
Student > Ph. D. Student 7 14%
Researcher 7 14%
Student > Master 3 6%
Student > Doctoral Student 2 4%
Other 5 10%
Unknown 16 32%
Readers by discipline Count As %
Medicine and Dentistry 20 40%
Biochemistry, Genetics and Molecular Biology 5 10%
Agricultural and Biological Sciences 4 8%
Nursing and Health Professions 1 2%
Immunology and Microbiology 1 2%
Other 3 6%
Unknown 16 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2023.
All research outputs
#4,972,158
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#244
of 2,501 outputs
Outputs of similar age
#33,339
of 165,962 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#4
of 13 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 165,962 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.